Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Inside the Bloodbath at the NIH. Sources say that a climate of fear has spread throughout the agency as the Trump administration takes a hatchet to its core functions.

    5. Juni 2025

    Al Qaeda Refuses to Die – The Cipher Brief

    4. Juni 2025

    The Pros and Cons of Bluetooth Speakers

    4. Juni 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»Health»Abbott wins FDA approval for mitral valve replacement device, teeing up Edwards competition
    Health

    Abbott wins FDA approval for mitral valve replacement device, teeing up Edwards competition

    HealthradarBy Healthradar1. Juni 2025Keine Kommentare2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Abbott wins FDA approval for mitral valve replacement device, teeing up Edwards competition
    Share
    Facebook Twitter LinkedIn Pinterest Email


    This audio is auto-generated. Please let us know if you have feedback.

    Dive Brief:

    • Abbott said Tuesday it received Food and Drug Administration approval for the Tendyne transcatheter mitral valve replacement system to treat calcium buildup in the ring that supports the heart valve.
    • The device is available for patients with severe mitral annular calcification who are not candidates for open heart surgery or transcatheter mitral valve repair.
    • Abbott’s MitraClip system for mitral valve repair competes with Edwards Lifesciences’ Pascal repair device. The rivals are now set to compete in mitral valve replacement: Edwards won Europe’s CE mark last month for the Sapien M3 transfemoral system and expects U.S. approval in 2026.

    Dive Insight:

    Abbott acquired Tendyne for $250 million in September 2015 and received CE mark approval for the system in January 2020. 

    “The approval culminates almost a decade of effort by Abbott,” Citi Research analyst Joanne Wuensch said in a report Tuesday, noting the commercialization of new valve technologies expands the options for patients.

    Severe mitral annular calcification prevents the heart from pumping blood effectively. Abbott said the Tendyne system addresses a significant unmet need in cardiac care, offering a minimally invasive way to replace the mitral valve for patients whose valves cannot be successfully repaired with MitraClip.

    „Patients with MAC can be very difficult to operate on and many are considered too high risk for open-heart surgery due to multiple co-morbidities or other factors. Tendyne bridges a critical treatment gap for these patients,” Paul Sorajja, director of the Center for Valve and Structural Heart Disease at the Minneapolis Heart Institute at Abbott Northwestern Hospital, said in Abbott’s statement.

    The self-expanding Tendyne valve is delivered to the heart through a small incision in the chest and is available in multiple sizes for a range of patient anatomies.



    Source link

    Abbott approval competition Device Edwards FDA mitral replacement teeing valve wins
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleSohar Health Unveils Network Status Tool to Streamline Behavioral Health Eligibility
    Next Article Forget Garmin: Samsung’s Galaxy Watch Ultra for 26% off is the better buy, with no paywall in sight
    ekass777x
    Healthradar
    • Website

    Related Posts

    Health

    Inside the Bloodbath at the NIH. Sources say that a climate of fear has spread throughout the agency as the Trump administration takes a hatchet to its core functions.

    5. Juni 2025
    Health

    3-Year Exercise Program Improves Colon Cancer Survival Rates

    4. Juni 2025
    Health

    watchOS 12: 3 things I expect to see Tim Cook announce at this year’s WWDC

    3. Juni 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Which Online Poker Game Should You Play?

    31. Mai 20259 Views

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20254 Views

    One In Four European Firms Ban Grok AI Chatbot Over Security Concerns

    1. Juni 20252 Views

    Bayer Launches Centafore Imaging Core Lab to Support Imaging for Clinical Trials and Software as a Medical Device Development

    1. Juni 20252 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Which Online Poker Game Should You Play?

    31. Mai 20259 Views

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20254 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.